Imran Khan’s Eye Vision Improves, Doctors Advise Further Tests And Care |
A recent medical examination of former prime minister Imran Khan has indicated notable improvement in vision in his right eye, according to a report issued by a two-member medical board in Islamabad.
The examination, conducted on February 15 by specialists from Al-Shifa Trust Eye Hospital and Pakistan Institute of Medical Sciences, recorded unaided vision in Khan’s right eye at 6/24 partial and 6/9 in the left. With corrective glasses, his vision improved to 6/9 partial in the right eye and 6/6 in the left, indicating substantial recovery.
Doctors noted reduced swelling in the affected eye, with central macular thickness decreasing from 550 to 350 — a key indicator of improvement. Khan had earlier been diagnosed with central retinal vein occlusion, a serious condition often linked to cardiovascular risk factors. The report described resolving macular oedema, attached retina, and improved foveal contour, suggesting a positive response to ongoing treatment, including anti-vascular endothelial growth factor therapy.
The medical board recommended continued medication, including anti-inflammatory and pressure-reducing eye drops, along with further diagnostic tests such as optical coherence tomography angiography and fundus fluorescein angiography to monitor recovery.
Meanwhile, Aasim Yusuf, Chief Medical Officer at Shaukat Khanum Memorial Cancer Hospital & Research Centre, said he could not independently confirm the findings, as he had not personally examined Khan. He urged authorities to allow independent doctors, including Faisal Sultan, to assess the former premier and recommended transferring him to Shifa International Hospital for further care.
Khan, who has been incarcerated since August 2023, had previously complained of severe vision loss in his right eye. His party initially raised concerns over medical evaluations conducted without family members or personal physicians present. However, the latest report states that his personal doctors were briefed and expressed satisfaction with the treatment provided.
Officials maintain there is no immediate cause for alarm, though continued monitoring and specialised testing have been advised to ensure sustained recovery.